SLC10A1 and cholestasis: These findings differ from a previous study of an estrogen-induced cholestasis rodent model reporting that OCA treatment induced bile flow and hepatocyte expression of Shp, Bsep, and Mrp-2 while repressing Ntcp and Cyp7a1 expression (15).